Stimcell Energetics (STME) Revenue Growth (3y) (2019 - 2023)
Stimcell Energetics (STME) Revenue Growth (3y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 2.92% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 7.43% |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -90.10% |
| Feb 28, 2023 | -54.65% |
| Nov 30, 2022 | -51.92% |
| Aug 31, 2022 | -70.60% |
| Feb 29, 2020 | 66.46% |
| Nov 30, 2019 | 212.33% |
| Aug 31, 2019 | 55.80% |